Global plasma protease C1-inhibitor treatment market is expected to grow at the highest CAGR in the upcoming years. C1-inhibitor is also known as C1-INH and C1 esterase inhibitor. C1-INH’s deficiency is the genetic defect underlying hereditary angioedema (HAE). 更多
